Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

Jaikumar Duraiswamy(Cancer Research Center), Riccardo Turrini(Ludwig Cancer Research), Aspram Minasyan(Ludwig Cancer Research), David Barras(SIB Swiss Institute of Bioinformatics), Isaac Crespo(Ludwig Cancer Research), Alizée J Grimm(Ludwig Cancer Research), Julia Casado(University of Helsinki), Raphaël Genolet(Ludwig Cancer Research), Fabrizio Benedetti(Ludwig Cancer Research), Alexandre Wicky(Precision for Medicine (United States)), Kalliopi Ioannidou(Ludwig Cancer Research), Wilson Castro(Ludwig Cancer Research), Christopher L. Neal(Ludwig Cancer Research), Amandine Moriot(Ludwig Cancer Research), Stéphanie Renaud-Tissot(Ludwig Cancer Research), Victor Anstett(Ludwig Cancer Research), Noémie Fahr(Ludwig Cancer Research), János L. Tanyi(Cancer Research Center), Monika A. Eiva(University of Pennsylvania), Connor A. Jacobson(Harvard University), Kathleen T. Montone(University of Pennsylvania), Marie Christine Wulff Westergaard(Herlev Hospital), Inge Marie Svane(Herlev Hospital), Lana E. Kandalaft(Ludwig Cancer Research), Mauro Delorenzi(SIB Swiss Institute of Bioinformatics), Peter K. Sorger(Harvard University), Anniina Färkkilä(University of Helsinki), Olivier Michielin(Precision for Medicine (United States)), Vincent Zoete(Ludwig Cancer Research), Santiago J. Carmona(Ludwig Cancer Research), Periklis Foukas(National and Kapodistrian University of Athens), Daniel J. Powell(University of Pennsylvania), Sylvie Rusakiewicz(Ludwig Cancer Research), Marie‐Agnès Doucey(Ludwig Cancer Research), Denarda Dangaj Laniti(Ludwig Cancer Research), George Coukos(University Hospital of Lausanne)
Cancer Cell
November 4, 2021
Cited by 187Open Access
Full Text

Abstract


Related Papers